Agree, need to verify the cancer diagnostic total industry value before making assumptions on revenue. My Illustration was not to suggest the share price will be $600 a share, it was more to prove a point that the $200B industry annual value could be incorrect. Agree - $10 to $20 is very realistic and only time will tell whether BD1 will become a 30+ bagger from here.
BD1's company update from last year shows the main cancer types and their yearly value, from memory it is not close to $200B total.
The real value in BD1 will come from their ability to penetrate the global markets - the tech is their - scaling the business will be difficult but doable. Can the BD1 team recruit quality professionals to negotiate offtake agreements globally. That is the true way the company's value will unlocked. Albeit, we'll probably be bought out before that time comes.
BD1 Price at posting:
$4.00 Sentiment: Hold Disclosure: Held
